Blog
Jones J (2023) Toxicology as a diagnostic tool to identify the misuse of drugs in the perinatal period. Front. Pediatr. 10:1071564. doi: 10.3389/fped.2022.1071564
Abstract
The use, misuse, and abuse of substances are a continued public health concern in this country and around the world. Perinatal exposure to substances of abuse is associated with several long-term negative consequences for the neonate. Limited resources exist to assist perinatal health professionals on this very complex subject. The purpose of this document is to provide additional information about selecting monitoring protocols, the specifics of appropriate testing methodologies, and the interpretation of toxicological findings. Understanding these concepts better allows perinatal healthcare professionals to be a voice for the voiceless in order to protect and enrich lives during this unprecedented opioid epidemic.
Acknowledgments
I would like to thank Loretta Finnegan for the encouragement to prepare this manuscript. Additionally, I would like to thank Guida Brown for reviewing and editing the paper.
Click here to read the full abstract. Click here to learn more about Newborn Testing.
- Forensic vs. Clinical Drug Testing: Why Flexibility Matters for Your Organization
- USDTL’s Integration and Partnership With CourtFact
- New Year, New Capabilities: Offering Forensic & Clinical Testing Options
- Weather Delay
- The Detection of Delta-9-tetrahydrocannabinol, Delta-8-tetrahydrocannabinol, Delta-10-tetrahydrocannabinol, and Cannabidiol in Hair Specimens
- Umbilical Cord Tissue Testing for Ketamine
- Drugs of Abuse: A DEA Resource Guide (2024)
- Beyond THC and CBD: Understanding New Cannabinoids
- February 2026 (1)
- January 2026 (3)
- October 2025 (1)
- July 2025 (3)
- May 2025 (2)
- April 2025 (2)


